News | RIVM

Details of proposed European PFAS ban released

Today, the European Chemicals Agency (ECHA) published details of a proposed ban on the production, use, sale and import of some 10,000 per- and polyfluoroalkyl substances (PFAS).

New risk limits for 18 pesticides in surface water

Evidence suggests that existing standards for some of these substances do not sufficiently protect the ecosystem. For others, no standards exist yet or the existing standards are outdated. If these

COVID-19 vaccine uptake related to neighbourhood demographics

COVID-19 vaccine uptake was lower in neighbourhoods that had proportionately higher percentages of residents from a non-Western migration background and residents who were more likely to vote for right-wing Christian and right-wing conservative political parties.

iStock

RIVM and TNO describe impact of future developments on occupational health and safety

RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work?

iStock

Provisional figures on participation in the National Immunisation Programme

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).

Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion

Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Preparations for COVID-19 vaccinations now in progress

RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.

R number rises to 1, decrease in newly reported COVID-19 infections slows

In the past week, the Municipal Health Services (GGDs) reported 36,931 new reports of confirmed COVID infections. This is about the same as in the previous week, when 37,706 new COVID-19 infections were reported (-2%).

New data on antimicrobial resistance in Europe

New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw